Summit Therapeutics
SMMT
SMMT
123 hedge funds and large institutions have $563M invested in Summit Therapeutics in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 20 increasing their positions, 47 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
3.22% more ownership
Funds ownership: 7.06% → 10.28% (+3.2%)
57% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 47
Holders
123
Holding in Top 10
1
Calls
$13.8M
Puts
$9.02M
Top Buyers
| 1 | +$181M | |
| 2 | +$15.7M | |
| 3 | +$15.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.88M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$15M | |
| 3 | -$3.86M | |
| 4 |
Rafferty Asset Management
New York
|
-$3.78M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.19M |